Terms: = Liver cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
75734 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
[TBL] [Abstract] [Full Text] [Related]
4. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
[TBL] [Abstract] [Full Text] [Related]
5. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Feng J; Zhao Y; Zhai L; Zhou J
Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
[TBL] [Abstract] [Full Text] [Related]
8. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
Jia W; Wu Q; Li R; Hou S; Kang C
Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
[TBL] [Abstract] [Full Text] [Related]
9. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
[TBL] [Abstract] [Full Text] [Related]
10. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
[TBL] [Abstract] [Full Text] [Related]
11. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
[TBL] [Abstract] [Full Text] [Related]
12. Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.
Xiong KG; Ke KY; Kong JF; Lin TS; Lin QB; Lin S; Zhu YY
World J Surg Oncol; 2024 May; 22(1):117. PubMed ID: 38698475
[TBL] [Abstract] [Full Text] [Related]
13. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
[TBL] [Abstract] [Full Text] [Related]
15. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
[TBL] [Abstract] [Full Text] [Related]
16. Expression of Fascin-1 and its diagnostic value in liver cancer.
Lu SP; Jiang LJ; Wang Y; Shao JK; Du ZQ; Huang BF; Wang CQ
Sci Rep; 2024 May; 14(1):10049. PubMed ID: 38698008
[TBL] [Abstract] [Full Text] [Related]
17. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank.
Liu Z; Huang H; Xie J; Xu Y; Xu C
Nat Commun; 2024 May; 15(1):3707. PubMed ID: 38697980
[TBL] [Abstract] [Full Text] [Related]
18. Current State of liver Transplantation for Cholangiocarcinoma: A Comprehensive Literature Review.
Mansoor J; Heaton N; Junaid Z
Exp Clin Transplant; 2024 Mar; 22(3):167-179. PubMed ID: 38695585
[TBL] [Abstract] [Full Text] [Related]
19. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.
Yang Y; Wang H; Si J; Zhang L; Ding H; Wang F; He L; Chen X
J Cancer Res Clin Oncol; 2024 Apr; 150(5):223. PubMed ID: 38691204
[TBL] [Abstract] [Full Text] [Related]
20. The application of a single-hand-operated hepatic pedicle clamping clamp in laparoscopic hepatectomy.
Shen Z; Jiang B; Chu H; Wang G; Fang X; Chen Z; Yang Y; Wang J; Wang X
Langenbecks Arch Surg; 2024 Apr; 409(1):146. PubMed ID: 38691172
[TBL] [Abstract] [Full Text] [Related]
[Next]
